See also this year's filing and all EDGAR filings for this company.
PDF Report 0001274792_2021_Merrimack_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001274792, Merrimack Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 16,544,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 232,000 |
| 4 | LiabilitiesCurrent | 770,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,707,359 |
| 9 | ResearchAndDevelopmentExpense | -2,492,451 |
| 10 | remainder_Expenses | -3,282,289 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,104,021 |
| 13 | remainder_ComprehensiveNetIncome | 2,006 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 16,776,000 |
| 1 | Liabilities | 770,000 |
| 2 | Expenses | -2,067,381 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 16,006,000 |
| 5 | NetIncome | 3,171,402 |
| 6 | ComprehensiveNetIncome | 3,172,405 |
| 7 | BaseVar | 10,359,704 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.34 |
| 9 | EconomicCapitalRatio | 4.65 |
Edgar->Model Mapping
Feature Distribution
Change over Time
